Table 1.
Dietary Strategy
--------------------------- Considerations and Predisposing Or Risk Factors |
Regular Small Meals | Modified Texture | Reduced Dietary fat |
Anti-inflammatory Diet | Reduced Protein | Gluten Free Diet | Modified Carbohydrate | Low FODMAP Trial | High Soluble Fibre | Reduced Fibre |
Low Chemical Diet | Low Food Additives | Probiotic Supplements | Prebiotic Supplements | Complementary Therapies | Reduced Caffeine |
Predisposing or risk factors for FD | ||||||||||||||||
Suspected duodenal microbiota alterations | ||||||||||||||||
Small intestinal bacterial overgrowth | ||||||||||||||||
Suspected immune or allergy-like response | ||||||||||||||||
Intestinal permeability |
. | ? L-glutamine | ||||||||||||||
Bile acid involvement |
||||||||||||||||
FD symptom-related | ||||||||||||||||
Delayed gastric emptying and/or impaired accommodation | . | Soluble | Ginger Iberogast | |||||||||||||
Early satiety |
||||||||||||||||
Wheat-induced symptoms |
||||||||||||||||
Pain |
Polyols | |||||||||||||||
Co-presenting extraintestinal symptoms (Atopy, migraine) | ||||||||||||||||
Post prandial distress |
dietary management approach suited to symptom or risk factor. ? dietary management option to consider (very limited evidence or only suitable for a subset of patients).